skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine (Code C70985)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine

Definition: An allogeneic whole cell vaccine, derived from irradiated allogenic tumor cells manipulated to express human B7.1 (CD80 antigen) and human leukocyte antigen (HLA) A1, with potential antitumor activity. Vaccination with allogeneic B7.1/HLA-A1 transfected tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor cell proliferation.

Label: Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine

NCI Thesaurus Code: C70985 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL376187  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 566437
PDQ Open Trial Search ID 566437 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C70985
Legacy_Concept_Name Allogeneic_B7_1_HLA-A1_Transfected_Tumor_Cell_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom